←Back to Expert Scholars
Translational Medicine / 转化医学Follicular Lymphoma Targeted Therapy
Krish Patel
MD
🏢Swedish Cancer Institute🌐USA
Lymphoma Specialist
28
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Krish Patel is a lymphoma specialist who has contributed to tazemetostat clinical development for EZH2-mutant follicular lymphoma. His work has helped establish molecular testing for EZH2 mutations as standard practice in FL management. He advocates for improving access to novel targeted therapies in community oncology settings.
Share:
🧪Research Fields 研究领域
Tazemetostat clinical trials
EZH2 mutation FL
Community lymphoma care
Novel agent access
Molecular testing FL
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Krish Patel 的研究动态
Follow Krish Patel's research updates
留下邮箱，当我们发布与 Krish Patel（Swedish Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment